• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国卡布基综合征患者的临床和分子特征。

Clinical and molecular characteristics of Korean patients with Kabuki syndrome.

机构信息

Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Medical Genetics Center, Asan Medical Center, Seoul, Republic of Korea.

出版信息

J Hum Genet. 2024 Sep;69(9):417-423. doi: 10.1038/s10038-024-01258-1. Epub 2024 Jun 1.

DOI:10.1038/s10038-024-01258-1
PMID:38824232
Abstract

INTRODUCTION

Kabuki syndrome (KS) is a rare disorder characterized by typical facial features, skeletal anomalies, fetal fingertip pad persistence, postnatal growth retardation, and intellectual disabilities. Heterozygous variants of the KMT2D and KDM6A genes are major genetic causes of KS. This study aimed to report the clinical and genetic characteristics of KS.

METHODS

This study included 28 Korean patients (14 boys and 14 girls) with KS through molecular genetic testing, including direct Sanger sequencing, whole-exome sequencing, or whole-genome sequencing.

RESULTS

The median age at clinical diagnosis was 18.5 months (IQR 7-58 months), and the median follow-up duration was 80.5 months (IQR 48-112 months). Molecular genetic testing identified different pathogenic variants of the KMT2D (n = 23) and KDM6A (n = 3) genes, including 15 novel variants. Patients showed typical facial features (100%), such as long palpebral fissure and eversion of the lower eyelid; intellectual disability/developmental delay (96%); short stature (79%); and congenital cardiac anomalies (75%). Although 71% experienced failure to thrive in infancy, 54% of patients showed a tendency toward overweight/obesity in early childhood. Patients with KDM6A variants demonstrated severe genotype-phenotype correlation.

CONCLUSION

This study enhances the understanding of the clinical and genetic characteristics of KS.

摘要

简介

歌舞伎综合征(KS)是一种罕见的疾病,其特征为典型的面部特征、骨骼异常、胎儿指尖垫持续存在、出生后生长迟缓以及智力障碍。KMT2D 和 KDM6A 基因的杂合变异是 KS 的主要遗传原因。本研究旨在报告 KS 的临床和遗传特征。

方法

本研究通过分子遗传学检测,包括直接 Sanger 测序、外显子组测序或全基因组测序,纳入了 28 名韩国 KS 患者(14 名男孩和 14 名女孩)。

结果

临床诊断时的中位年龄为 18.5 个月(IQR 7-58 个月),中位随访时间为 80.5 个月(IQR 48-112 个月)。分子遗传学检测发现了 KMT2D(n=23)和 KDM6A(n=3)基因的不同致病性变异,包括 15 个新变异。患者表现出典型的面部特征(100%),如长睑裂和下眼睑外翻;智力障碍/发育迟缓(96%);身材矮小(79%);和先天性心脏异常(75%)。尽管 71%的患者在婴儿期存在生长不良,但 54%的患者在幼儿期有超重/肥胖的趋势。KDM6A 变异患者表现出严重的基因型-表型相关性。

结论

本研究加深了对 KS 的临床和遗传特征的认识。

相似文献

1
Clinical and molecular characteristics of Korean patients with Kabuki syndrome.韩国卡布基综合征患者的临床和分子特征。
J Hum Genet. 2024 Sep;69(9):417-423. doi: 10.1038/s10038-024-01258-1. Epub 2024 Jun 1.
2
Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome.通过外显子组测序鉴定韩国歌舞伎综合征患者中的KMT2D和KDM6A突变。
J Hum Genet. 2014 Jun;59(6):321-5. doi: 10.1038/jhg.2014.25. Epub 2014 Apr 17.
3
The phenotypic spectrum of Kabuki syndrome in patients of Chinese descent: A case series.中国血统患者的歌舞伎综合征表型谱:病例系列。
Am J Med Genet A. 2020 Apr;182(4):640-651. doi: 10.1002/ajmg.a.61467. Epub 2019 Dec 28.
4
Mutation Update for Kabuki Syndrome Genes KMT2D and KDM6A and Further Delineation of X-Linked Kabuki Syndrome Subtype 2.歌舞伎综合征相关基因KMT2D和KDM6A的突变更新及X连锁歌舞伎综合征2型的进一步细化
Hum Mutat. 2016 Sep;37(9):847-64. doi: 10.1002/humu.23026. Epub 2016 Jul 7.
5
Kabuki syndrome: novel pathogenic variants, new phenotypes and review of literature.歌舞伎综合征:新的致病性变异体、新的表型及文献复习。
Orphanet J Rare Dis. 2019 Nov 14;14(1):255. doi: 10.1186/s13023-019-1219-x.
6
Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders.通过对卡布奇综合征和其他先天性疾病患者的靶向测序鉴定 KMT2D 和 KDM6A 变异。
Gene. 2020 Mar 20;731:144360. doi: 10.1016/j.gene.2020.144360. Epub 2020 Jan 11.
7
MLL2 and KDM6A mutations in patients with Kabuki syndrome.卡布列综合征患者中的 MLL2 和 KDM6A 突变。
Am J Med Genet A. 2013 Sep;161A(9):2234-43. doi: 10.1002/ajmg.a.36072. Epub 2013 Aug 2.
8
Prenatal and perinatal history in Kabuki Syndrome.先天性肾上腺皮质增生症的产前和围产期病史。
Am J Med Genet A. 2020 Jan;182(1):85-92. doi: 10.1002/ajmg.a.61387. Epub 2019 Oct 26.
9
Clinical and molecular characterization study of Chinese Kabuki syndrome in Hong Kong.中国香港卡布奇诺综合征的临床和分子特征研究。
Am J Med Genet A. 2021 Mar;185(3):675-686. doi: 10.1002/ajmg.a.62003. Epub 2020 Dec 13.
10
Investigation of genetic and phenotypic heterogeneity in 37 Turkish patients with Kabuki and Kabuki-like phenotype.37 例土耳其卡布奇诺和卡布奇诺样表型患者的遗传和表型异质性研究。
Am J Med Genet A. 2022 Oct;188(10):2976-2987. doi: 10.1002/ajmg.a.62944. Epub 2022 Aug 8.

引用本文的文献

1
Neurological Complications in Inborn Errors of Immunity: A Scoping Review of Clinical Spectrum, Pathophysiological Mechanisms, and Therapeutic Strategies.免疫缺陷病的神经系统并发症:临床谱、病理生理机制及治疗策略的范围综述
Clin Rev Allergy Immunol. 2025 Jul 18;68(1):67. doi: 10.1007/s12016-025-09078-7.

本文引用的文献

1
From Genotype to Phenotype-A Review of Kabuki Syndrome.从基因型到表型——歌舞伎综合征综述。
Genes (Basel). 2022 Sep 29;13(10):1761. doi: 10.3390/genes13101761.
2
An HNRNPK-specific DNA methylation signature makes sense of missense variants and expands the phenotypic spectrum of Au-Kline syndrome.一个 HNRNPK 特异性 DNA 甲基化特征解释了错义变异,并扩展了 Au-Kline 综合征的表型谱。
Am J Hum Genet. 2022 Oct 6;109(10):1867-1884. doi: 10.1016/j.ajhg.2022.08.014. Epub 2022 Sep 20.
3
Follow-Up Study of Growth Hormone Therapy in Children with Kabuki Syndrome: Two-Year Treatment Results.
歌舞伎综合征患儿生长激素治疗的随访研究:两年治疗结果
Horm Res Paediatr. 2021;94(7-8):285-296. doi: 10.1159/000519963. Epub 2021 Oct 4.
4
Clinical delineation, sex differences, and genotype-phenotype correlation in pathogenic KDM6A variants causing X-linked Kabuki syndrome type 2.导致 X 连锁性歌舞伎综合征 2 型的致病性 KDM6A 变异的临床特征、性别差异及基因型-表型相关性。
Genet Med. 2021 Jul;23(7):1202-1210. doi: 10.1038/s41436-021-01119-8. Epub 2021 Mar 5.
5
Diagnostic yield and clinical utility of whole exome sequencing using an automated variant prioritization system, EVIDENCE.使用自动化变异优先级系统 EVIDENCE 进行全外显子组测序的诊断收益和临床实用性。
Clin Genet. 2020 Dec;98(6):562-570. doi: 10.1111/cge.13848. Epub 2020 Sep 17.
6
Update of the genotype and phenotype of KMT2D and KDM6A by genetic screening of 100 patients with clinically suspected Kabuki syndrome.对 100 例临床疑似歌舞伎综合征患者进行基因筛查,更新 KMT2D 和 KDM6A 的基因型和表型。
Am J Med Genet A. 2020 Oct;182(10):2333-2344. doi: 10.1002/ajmg.a.61793. Epub 2020 Aug 17.
7
Aggressive desmoid fibromatosis in Kabuki syndrome: Expanding the tumor spectrum.歌舞伎综合征中的侵袭性韧带样纤维瘤病:拓宽肿瘤谱
Pediatr Blood Cancer. 2019 Sep;66(9):e27831. doi: 10.1002/pbc.27831. Epub 2019 May 27.
8
Exploring the cognitive phenotype of Kabuki (Niikawa-Kuroki) syndrome.探讨歌舞伎(Niikawa-Kuroki)综合征的认知表型。
J Intellect Disabil Res. 2019 Jun;63(6):498-506. doi: 10.1111/jir.12597. Epub 2019 Feb 6.
9
Dissecting KMT2D missense mutations in Kabuki syndrome patients.解析卡波济氏综合征患者 KMT2D 错义突变。
Hum Mol Genet. 2018 Nov 1;27(21):3651-3668. doi: 10.1093/hmg/ddy241.
10
Correction: "Congenital hyperinsulinism as the presenting feature of Kabuki syndrome: clinical and molecular characterization of 10 affected individuals".更正:“先天性高胰岛素血症作为歌舞伎综合征的首发特征:10例受累个体的临床和分子特征”
Genet Med. 2019 Jan;21(1):262-265. doi: 10.1038/s41436-018-0126-1.